Qube Research & Technologies (QRT)’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,101
Closed -$54.8K 4507
2023
Q4
$54.8K Buy
+3,101
New +$62.5K ﹤0.01% 3289
2021
Q3
Sell
-14,646
Closed -$570K 2270
2021
Q2
$570K Sell
14,646
-13,224
-47% -$474K 0.01% 1220
2021
Q1
$802K Buy
+27,870
New +$952K 0.01% 943
2020
Q4
Sell
-58,621
Closed -$895K 1852
2020
Q3
$895K Buy
+58,621
New +$1.23M 0.01% 837
2018
Q4
Sell
-1,446
Closed -$167K 405
2018
Q3
$167K Buy
1,446
+995
+221% +$112K 0.02% 568
2018
Q2
$57K Buy
+451
New +$54.9K 0.04% 469

Other funds holding CLB

Qube Research & Technologies (QRT)'s CLB Position: Q1 2024 in Review

Qube Research & Technologies (QRT) sold out of Core Laboratories (CLB) in Q1 2024, closing a stake of 3,101 shares — an estimated $54.8K sold.

Qube Research & Technologies (QRT) first reported a position in CLB in Q2 2018 and held it in 6 quarters. The position peaked at $895K in Q3 2020. 197 funds tracked by Wall St. Rank hold CLB as of Q1 2024.

  • Qube Research & Technologies (QRT) reported no remaining Core Laboratories position as of Q1 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 3,101 Core Laboratories shares in Q1 2024, an estimated $54.8K.
  • Qube Research & Technologies (QRT) first reported a position in Core Laboratories in Q2 2018 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s Core Laboratories position peaked at $895K in Q3 2020.
  • 197 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2024, filed 14 May 2024.